Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCoherus Oncology Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.35 | -$0.18 | -$0.26 |
| Q2 2026 | 1 | -$0.33 | -$0.16 | -$0.25 |
| Q3 2026 | 1 | -$0.31 | -$0.15 | -$0.23 |
| Q4 2026 | 1 | -$0.34 | -$0.17 | -$0.26 |
| Q1 2027 | 1 | -$0.23 | -$0.11 | -$0.17 |
| Q2 2027 | 1 | -$0.23 | -$0.11 | -$0.17 |
| Q3 2027 | 1 | -$0.25 | -$0.13 | -$0.19 |
| Q4 2027 | 1 | -$0.25 | -$0.13 | -$0.19 |
| Q1 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 0 | $0.00 | $0.00 | $0.00 |
Coherus Oncology Inc. Earnings Date And Information
Coherus Oncology Inc. last posted its earnings results on Monday, May 11th, 2026. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.26333 by $0.01333. The company had revenue of 12.31 M for the quarter and had revenue of 42.17 M for the year. Coherus Oncology Inc. has generated $-1 earnings per share over the last year ($-1.45 diluted earnings per share) and currently has a price-to-earnings ratio of 1.25. Coherus Oncology Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Coherus Oncology Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/11/2026 | Q1 2026 | -$0.26 | -$0.28 | -0.02 | $14.22 M | $12.31 M |
| 03/09/2026 | Q4 2025 | -$0.36 | -$0.31 | 0.05 | $13.91 M | $12.75 M |
| 11/06/2025 | Q3 2025 | -$0.32 | -$0.30 | 0.02 | $13.36 M | $11.57 M |
| 08/07/2025 | Q2 2025 | -$0.31 | -$0.39 | -0.08 | $9.35 M | $10.25 M |
| 05/12/2025 | Q1 2025 | -$0.31 | -$0.49 | -0.18 | $54.67 M | $7.60 M |
| 03/17/2025 | Q4 2024 | N/A | -$0.44 | N/A | $44.15 M | $54.14 M |
| 11/06/2024 | Q3 2024 | -$0.10 | -$0.09 | 0.01 | $58.98 M | $70.77 M |
| 08/08/2024 | Q2 2024 | -$0.21 | -$0.11 | 0.1 | $62.06 M | $64.98 M |
| 05/09/2024 | Q1 2024 | -$0.05 | $0.91 | 0.96 | $81.70 M | $2.31 M |
| 03/15/2024 | Q4 2023 | N/A | -$0.71 | N/A | N/A | $91.52 M |
| 11/06/2023 | Q3 2023 | -$0.21 | -$0.41 | -0.2 | N/A | $74.57 M |
| 08/02/2023 | Q2 2023 | -$0.52 | -$0.49 | 0.03 | N/A | $58.72 M |
| 05/08/2023 | Q1 2023 | -$0.61 | -$0.94 | -0.33 | N/A | $32.44 M |
| 03/06/2023 | Q4 2022 | -$0.64 | -$0.85 | -0.21 | N/A | $45.35 M |
| 11/08/2022 | Q3 2022 | -$0.53 | -$1.19 | -0.66 | N/A | $45.42 M |
| 08/04/2022 | Q2 2022 | -$0.96 | -$0.73 | 0.23 | N/A | $60.15 M |
| 05/05/2022 | Q1 2022 | -$0.80 | -$1.44 | -0.64 | N/A | $60.12 M |
| 02/23/2022 | Q4 2021 | N/A | -$0.60 | N/A | N/A | $73.37 M |
| 11/08/2021 | Q3 2021 | -$0.40 | -$0.49 | -0.09 | N/A | $82.50 M |
| 08/05/2021 | Q2 2021 | -$0.25 | -$0.40 | -0.15 | N/A | $87.64 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Coherus Oncology Inc. Earnings: FAQ's
In the previous quarter, Coherus Oncology Inc. (:CHRS) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.26333 by $0.01333.
The conference call for Coherus Oncology Inc.'s latest earnings report can be listened to online.
The conference call transcript for Coherus Oncology Inc.'s latest earnings report can be read online.
Coherus Oncology Inc. (:CHRS) has a recorded annual revenue of $42.17 M.
Coherus Oncology Inc. (:CHRS) has a recorded net income of $-170,291,000.Coherus Oncology Inc. has generated $-1.45 earnings per share over the last four quarters.
Coherus Oncology Inc. (:CHRS) has a price-to-earnings ratio of 1.25 and price/earnings-to-growth ratio is -0.06.